Labelling Review row-Online
Labelling Review row-Online
Labelling Review row-Online
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Primary Antibodies<br />
Terminal Deoxynucleotidyl Transferase<br />
Clone SEN28<br />
1 mL, 0.1 mL lyophilized NCL-TdT-339 P (HIER) W<br />
1 mL liquid NCL-L-TdT-339 P (HIER) W<br />
7 mL ready-to-use RTU-TdT-339 P (HIER)<br />
7 mL Bond ready-to-use PA0339 P (HIER)<br />
Terminal deoxynucleotidyl transferase (TdT) is a DNA polymerase of 58 kD<br />
located in the cell nucleus which catalyzes the polymerization of<br />
deoxynucleotides at the 3' hydroxyl ends of oligo or polydeoxynucleotide<br />
initiators and functions without a template. TdT is reported to be expressed<br />
in primitive T and B lymphocytes of the normal thymus and bone mar<strong>row</strong>.<br />
The identification of TdT-positive cell populations in primary and secondary<br />
lymphoid organs during maturation of the immune system is one area of<br />
interest but it is the reported occurrence of high levels of enzyme activity in<br />
white blood cells and bone mar<strong>row</strong> in certain leukemias which is of<br />
particular interest. Early and precise differentiation of lymphoblastic<br />
lymphoma is crucial. TdT is reported to be expressed in lymphoblastic<br />
lymphomas and leukemias. The determination of TdT expression is reported<br />
to be most valuable when it is difficult to differentiate histologically between<br />
lymphoblastic lymphoma and Burkitt's lymphoma.<br />
Refer to page 42 for the Bond ready-to-use format.<br />
Human lymphoblastic lymphoma: immunohistochemical staining for terminal deoxynucleotidyl<br />
transferase using NCL-TdT-339. Note intense nuclear staining of tumor cells. Paraffin section.<br />
Thrombomodulin (CD141)<br />
Clone 15C8<br />
1 mL, 0.1 mL lyophilized NCL-CD141 F P (HIER)<br />
Thrombomodulin is a transmembrane glycoprotein of 75 kD which can<br />
accelerate the activation of protein C. Activated protein C functions as an<br />
anticoagulant by combining with protein S to inactivate factors Va and VIIIa<br />
of the blood coagulation pathway and by binding thrombin. Several factors<br />
regulate thrombomodulin expression. Downregulation of thrombomodulin<br />
may be induced by the cytokine interleukin-1, tumor necrosis factor and<br />
endotoxin. Agents which increase cyclic AMP such as forskolin may<br />
upregulate thrombomodulin activity in endothelial cells. Thrombomodulin<br />
has been identified within a number of normal tissues. These include the<br />
lining cells of arteries, veins, capillaries and the lymphatics as well as<br />
mesothelial cells, meningeal lining cells, synovial cells, syncytiotrophoblasts,<br />
megakaryocytes and platelets. It is reported that in oral<br />
squamous cell carcinomas, the reduction of thrombomodulin expression<br />
may play a role in metastasis. Thrombomodulin protein is reported to be<br />
absent from most pulmonary adenocarcinomas but is expressed in<br />
malignant pleural mesotheliomas, vascular tumors and choriocarcinomas.<br />
/ 162<br />
For detailed information on all products please visit our website:<br />
www.leica-microsystems.com<br />
Reference Range<br />
Thymus and Activation-Regulated<br />
Chemokine<br />
Clone 6SN<br />
1 mL lyophilized NCL-TARC P (HIER)<br />
The attraction of leukocytes to sites of inflammation is a process controlled<br />
by chemokines. Chemokines are a group of proteins of 8 to 10 kD that are<br />
divided into four families based on their first two cysteine residues in the<br />
conserved motif. Thymus and activation-regulated chemokine (TARC)<br />
functions as a selective chemoattractant for T cells which express a class of<br />
receptors binding TARC with high affinity and specificity. TARC has been<br />
identified as the specific ligand for the CC chemokine receptor 4 (CCR4)<br />
which is preferentially expressed at high levels in activated T helper 2 (Th2)<br />
cells. It is reported to be constitutively expressed in the dendritic cells of the<br />
thymus and transiently in activated peripheral blood mononuclear cells. It is<br />
present in the cell cytoplasm with frequent paranuclear condensation.<br />
Reports indicate that TARC is overexpressed in nodular sclerosis (NS) and<br />
mixed cellularity (MC) classical Hodgkin's disease but not in non-Hodgkin's<br />
lymphomas, anaplastic large cell lymphomas and large B cell lymphomas<br />
with CD30 positivity. Reed Sternberg cells of NS and MC Hodgkin's<br />
lymphomas show high levels of TARC protein. Furthermore, in classical<br />
Hodgkin's disease, TARC's ability to attract activated T cells by strong<br />
association to the chemokine receptor, CCR4, may explain the characteristic<br />
T cell infiltrate. It has also been suggested that TARC may also play a role in<br />
platelet activation, via CCR4, seen in Th2-associated diseases such as<br />
asthma and atopic dermatitis.<br />
Human cervical lymph node, Hodgkin's disease: immunohistochemical staining for thymus and<br />
activation-regulated chemokine (TARC) using NCL-TARC. Note characteristic staining of Reed<br />
Sternberg cells. Paraffin section.<br />
Thyroglobulin<br />
Clone 1D4<br />
1 mL liquid NCL-L-THY FP<br />
7 mL Bond ready-to-use PA0025 P<br />
Thyroglobulin is a heavily glycosylated protein of 670kD composed of two<br />
identical subunits and is synthesised by the follicular epithelial cells of the<br />
thyroid. Thyroglobulin provides iodination sites for the formation of the<br />
thyroid hormones.<br />
Refer to page 42 for the Bond ready-to-use format.<br />
Products in this catalog are subject to regulatory approval.<br />
This catalog is not for use in the USA.